The Validity of Kleinhauer Betke in Women With Known Hemoglobinopathy for Fetal-maternal Hemorrhage

Hillel Yaffe Medical Center27 enrolled

Overview

The aim of this study is to determine the validity of Kleinhauer Betke in women with known hemoglobinopathy for fetal-maternal hemorrhage.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Fetal-Maternal Hemorrhage

Interventions

Blood testDIAGNOSTIC_TEST

Standard blood test

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Pregnant with singleton fetus * Gestational age 34-42 * With or without known hemoglobinopathy Exclusion Criteria: * Known risk factor for fetal maternal hemorrhage

Locations (1)

Hille Yaffe Medical Center

Hadera, Israel

Outcomes

Primary Outcomes

Validity of Kleinhauer Betke test in Pregnant Women

Comparison of Kleinhauer Betke results with electrophoresis results to determine presence of F-hemoglobin. This would indicate the validity of the Kleinhauer Betke test in women with hemoglobinopathy

Time frame: 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.